Results 91 to 100 of about 1,949,085 (259)
, 1943 The Compressometer, developed at the National Bureau of Standards, by Herbert F. Schiefer in 1933, is an instrument in which a fabric specimen is placed upon a flat surface and the fabric thickness is measured as a function of an applied variable ...
Schiefer, Herbert F.; Frazier Precision Instrument Co.
core
Molecular Oncology, EarlyView.Radiotherapy (RT) response depends on the DNA repair capacity of tumor and host cells. We show that circulating tumor cell (CTC) counts and apoptosis rates before and after RT predict treatment response and outcome, which can be accessed via easily accessible liquid biopsy approaches. Created in BioRender. Wikman, H.
Yvonne Goy +10 more
wiley +1 more source
Molecular Oncology, EarlyView.A urine‐based digital PCR assay targeting two hotspot TERT promoter variants detected bladder cancer with high sensitivity and no false positives in this case–control cohort. The streamlined AbsoluteQ workflow outperformed Sanger sequencing and supports non‐invasive molecular testing for bladder cancer detection.
Anna Nykel +12 more
wiley +1 more source
Optimum Monetary Instrument Option in the Case of a Small Open Economy [PDF]
This essay examines the choice of monetary policy instrument for a small open economy under flexible exchange rate regime with some reference to Indonesia.
Arief Ramayandi
core
Molecular Oncology, EarlyView.This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska +13 more
wiley +1 more source
Model engine data sheets and operating instructions, P - S, 1942, 1990, 1998
, 1942 Operating instructions for the Northfield-Ross 60 Twin model ...
Northfeild Precision Instrument Corporation
core +1 more source
Molecular Oncology, EarlyView.Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura +19 more
wiley +1 more source